Financial assistance may be available to help you with the cost of Elevidys. your treatment plan your insurance coverage the cost of the visit to your healthcare professional to receive doses of ...
HealthDay on MSN1d
Sarepta’s Gene Therapy Under Scrutiny After Patient DeathA patient has died while receiving Elevidys, a gene therapy for Duchenne muscular dystrophy, marking the first known death ...
Genetic medicine firm Sarepta Therapeutics announced the tragic death of a young man with Duchenne muscular dystrophy (DMD) ...
Cambridge-based Sarepta Therapeutics said Tuesday that a patient died while taking its closely watched gene therapy for ...
Gene therapy developer Sarepta Therapeutics (NASDAQ:SRPT) lost ~20% on Tuesday to reach a new 52-week low after the company disclosed the death of a patient treated with Elevidys, its FDA-approved ...
Sarepta Therapeutics (SRPT) stock is reeling this week following the death of a 16-year-old patient treated with its flagship gene therapy, ...
Sarepta reported a patient death from acute liver failure after Elevidys treatment, though no new safety signal was identified. Over 800 patients have received Elevidys, and a recent CMV infection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback